Last edition
News about "Chronic rhinosinusitis with nasal polyps"
China Approves GSK's Exdensur for Chronic Rhinosinusitis with Nasal Polyps
GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on therapy for adult patients with Chronic Rhinosinusitis with Nasal Polyps who remain inadequately controlled with systemic corticosteroids or surgery.
Chronic Rhinosinusitis With Nasal Polyps | 09/04/2026 | By Darshana
Sanofi's Lunsekimig Shows Promising Phase II Results in Asthma and Nasal Polyps Studies
The novel dual-targeting Nanobody met primary and key secondary endpoints in asthma and chronic rhinosinusitis trials, demonstrating improved outcomes and a favourable safety profile.
Chronic Rhinosinusitis With Nasal Polyps | 08/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy